1
|
Fresneau B, Dourthe ME, Jouin A, Laurence V, de Lambert G, Colas C, Coret M, Laprie A, Rebours C, Orbach D, Demoor-Goldschmidt C. Carcinomes des adolescents et jeunes adultes : quelles spécificités ? Bull Cancer 2017; 104:267-280. [DOI: 10.1016/j.bulcan.2016.11.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2016] [Revised: 11/14/2016] [Accepted: 11/17/2016] [Indexed: 01/23/2023]
|
2
|
Villamayor Martín R, Bartucci A, Muñoz Calvo MT, Pozo Román J, Argente J. Mutation in RET gene: Prophylactic thyroidectomy and postoperative follow-up. ANALES DE PEDIATRÍA (ENGLISH EDITION) 2016. [DOI: 10.1016/j.anpede.2016.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
3
|
Villamayor Martín R, Bartucci A, Muñoz Calvo MT, Pozo Román J, Argente J. [Mutation in RET gene: Prophylactic thyroidectomy and postoperative follow-up]. An Pediatr (Barc) 2016; 85:266-267. [PMID: 26809756 DOI: 10.1016/j.anpedi.2015.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Revised: 11/12/2015] [Accepted: 12/14/2015] [Indexed: 10/22/2022] Open
Affiliation(s)
- Raquel Villamayor Martín
- Servicio de Endocrinología, Hospital Infantil Universitario Niño Jesús, Madrid, España; Departamento de Pediatría, Universidad Autónoma de Madrid, Madrid, España; Centro de Investigación Biomédica en Red sobre Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España
| | - Andrea Bartucci
- Servicio de Endocrinología, Hospital Infantil Universitario Niño Jesús, Madrid, España; Departamento de Pediatría, Universidad Autónoma de Madrid, Madrid, España; Centro de Investigación Biomédica en Red sobre Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España
| | - María Teresa Muñoz Calvo
- Servicio de Endocrinología, Hospital Infantil Universitario Niño Jesús, Madrid, España; Departamento de Pediatría, Universidad Autónoma de Madrid, Madrid, España; Centro de Investigación Biomédica en Red sobre Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España.
| | - Jesús Pozo Román
- Servicio de Endocrinología, Hospital Infantil Universitario Niño Jesús, Madrid, España; Departamento de Pediatría, Universidad Autónoma de Madrid, Madrid, España; Centro de Investigación Biomédica en Red sobre Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España
| | - Jesús Argente
- Servicio de Endocrinología, Hospital Infantil Universitario Niño Jesús, Madrid, España; Departamento de Pediatría, Universidad Autónoma de Madrid, Madrid, España; Centro de Investigación Biomédica en Red sobre Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España
| |
Collapse
|
4
|
Segura D, Dupuis C, Chabre O, Piolat C, Durand C, Plantaz D. [Metastatic medullary thyroid carcinoma in a child with multiple endocrine neoplasia 2B. Efficiency of medium-term treatment with vandetanib without thyroid surgery]. Arch Pediatr 2016; 23:840-4. [PMID: 27345554 DOI: 10.1016/j.arcped.2016.05.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2015] [Revised: 02/02/2016] [Accepted: 05/20/2016] [Indexed: 11/25/2022]
Abstract
Medullary thyroid carcinoma (MTC) is a rare cancer during childhood. MTC is sporadic in approximately 80% of cases and hereditary in 20%. When hereditary, it can be associated with other endocrine neoplasias and/or typical nonendocrine diseases, thus configuring the multiple endocrine neoplasia (MEN) syndromes. Children with clinically obvious MTC belong to MEN 2A or 2B families, related to RET mutations. The standard treatment is total thyroidectomy and central neck dissection. However, treatment of advanced MTC has not yet been standardized, even if a new tyrosine kinase inhibitor specific to RET mutation has changed the outcome of such patients. Vandetanib plays a role in the treatment of children with metastatic, locally advanced and nonoperable MTC, with good tolerance. We report the 5-year treatment of an 11-year-old patient, with vandetanib and without thyroid surgery.
Collapse
Affiliation(s)
- D Segura
- Clinique universitaire de pédiatrie, CHU de Grenoble, CS 10217, 38043 Grenoble cedex, France.
| | - C Dupuis
- Clinique universitaire de pédiatrie, CHU de Grenoble, CS 10217, 38043 Grenoble cedex, France
| | - O Chabre
- Clinique universitaire d'endocrinologie, CHU de Grenoble, CS 10217, 38043 Grenoble cedex, France
| | - C Piolat
- Clinique universitaire de chirurgie pédiatrique, CHU de Grenoble, CS 10217, 38043 Grenoble cedex, France
| | - C Durand
- Clinique universitaire d'imagerie pédiatrique, CHU de Grenoble, CS 10217, 38043 Grenoble cedex, France
| | - D Plantaz
- Clinique universitaire de pédiatrie, CHU de Grenoble, CS 10217, 38043 Grenoble cedex, France
| |
Collapse
|